アジア太平洋の高活性API市場 - 分析と予測（2023年～2033年）

アジア太平洋の高活性APIの市場規模は、2023年の74億9,000万米ドルから2033年には256億8,000万米ドルに達し、予測期間の2023年～2033年のCAGRは13.11%になると予測されています。

がんの有病率の増加が高活性APIの需要を促進しており、様々な医学的疾患におけるこれらの高活性APIの治療用途の拡大が、APACの高活性API市場の成長を促進する主な要因です。

アジア太平洋の高活性医薬品成分（HPAPI）市場は、慢性疾患の蔓延と標的治療薬のニーズの高まりにより急速に拡大しています。HPAPIは、特にホルモンバランスの乱れ、がん、その他特定の病状の治療において、極めて強力な薬剤を作り出す上で重要な役割を果たしています。この地域の製薬産業が発展し、製造能力と技術が向上したおかげで、市場は拡大しています。

この拡大をリードしているのは、強力なインフラ、熟練労働者、成長を促す法的枠組みから利益を得ている国々です。さらに、製造受託機関（CMO）の成長と研究開発への投資拡大により、市場の潜在力はさらに高まっています。

当レポートでは、アジア太平洋の高活性API市場について調査し、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

• 動向：現在および将来の影響評価
• サプライチェーン/価値概要
• 価格分析
• 特許出願動向（年別、国別）
• 規制状況
• 主要な世界的出来事の影響分析-COVID-19
• 市場力学：概要

第2章 地域

• 地域別概要
• アジア太平洋

第3章 市場-競合ベンチマーキングと企業プロファイル

• 今後の見通し
• 地理的評価
  • Asymchem Inc.
  • Dr. Reddy's Laboratories Ltd.
  • CARBOGEN AMCIS

第4章 調査手法

List of Figures

• Figure 1: Highly Potent API Market, Recent Developments
• Figure 2: Highly Potent API Market: Value Chain Analysis
• Figure 3: Highly Potent API Market: Pricing Analysis
• Figure 4: Highly Potent API Market, Patent Analysis (by Year), January 2018-December 2023
• Figure 5: Highly Potent API Market, Patent Analysis (by Country), January 2018-December 2023
• Figure 6: Regulatory Framework for Highly Potent API
• Figure 7: Impact Analysis of Market Navigating Factors, 2022-2033
• Figure 8: Incidence of Cancer (by Region), Million, 2020-2040
• Figure 9: Asia-Pacific Highly Potent API Market, $Billion, 2022-2033
• Figure 10: China Highly Potent API Market, $Billion, 2022-2033
• Figure 11: India Highly Potent API Market, $Billion, 2022-2033
• Figure 12: Japan Highly Potent API Market, $Billion, 2022-2033
• Figure 13: Australia Highly Potent API Market, $Billion, 2022-2033
• Figure 14: South Korea Highly Potent API Market, $Billion, 2022-2033
• Figure 15: Rest-of-Asia-Pacific Highly Potent API Market, $Billion, 2022-2033
• Figure 16: Some of the Key Innovators in the Highly Potent API Landscape
• Figure 17: Highly Potent API Market: Geographical Assessment
• Figure 18: Strategic Initiatives, January 2021-December 2023
• Figure 19: Share of Strategic Initiatives
• Figure 20: Data Triangulation
• Figure 21: Top-Down and Bottom-Up Approach
• Figure 22: Assumptions and Limitations

List of Tables

• Table 1: Asia-Pacific Highly Potent API Market Snapshot
• Table 2: Short-Term and Long-Term Opportunities and Risks (by Region)
• Table 3: Key Trends, Impact Analysis
• Table 4: Highly Potent API Market, Key Investment
• Table 5: Recent Innovations for Manufacturing and Handling of Highly Potent Drugs
• Table 6: Highly Potent API Market (by Region), $Billion, 2022-2033
• Table 7: Highly Potent API Market (by Country), $Billion, 2022-2033

Introduction to Asia-Pacific (APAC) Highly Potent API Market

The Asia-Pacific highly potent API market is projected to reach $25.68 billion by 2033 from $7.49 billion in 2023, growing at a CAGR of 13.11% during the forecast period 2023-2033. The increasing prevalence of cancer is driving the demand for highly potent APIs, and the expanding therapeutic applications of these potent APIs across a range of medical disorders are the main factors driving the growth of the APAC extremely potent API market.

Market Introduction

The market for highly potent active pharmaceutical ingredients (HPAPI) in Asia-Pacific is expanding quickly due to the growing prevalence of chronic illnesses and the growing need for targeted therapeutics. HPAPIs play a crucial role in the creation of extremely potent drugs, especially in the treatment of hormone imbalances, cancer, and other specific medical conditions. The market is growing thanks to the region's developing pharmaceutical industry, as well as improvements in manufacturing capacity and technology.

Leading the way in this expansion are nations which gain from strong infrastructure, highly skilled workers, and legislative frameworks that encourage growth. Additionally, the market's potential is being further enhanced by the growth of contract manufacturing organizations (CMOs) and greater investment in research and development. This research explores the APAC HPAPI market's future trends, key players, regulatory landscape, and current market dynamics, offering insightful information to stakeholders hoping to take advantage of new business possibilities in this rapidly expanding industry.

Market Segmentation

Segmentation 1: by Region

• China
• Japan
• India
• South Korea
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Competitive Strategy: The Asia-Pacific highly potent API market has numerous established players with product and service portfolios. Key players in the Asia-Pacific highly potent API market analysed and profiled in the study involve established players offering product and services of highly potent API.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, type portfolio, and market penetration.

Some prominent names in the market include:

• Asymchem Inc.
• Dr. Reddy's Laboratories Ltd.
• CARBOGEN AMCIS

Table of Contents

Executive Summary

Scope and Definition

1 Markets

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Trend 1: Advancements in Containment Technologies for Highly Potent APIs
  • 1.1.2 Trend 2: Increasing Investment for Highly Potent API Manufacturing Units
  • 1.1.3 Trend 3: Pharmaceutical Companies Outsourcing Highly Potent APIs Production to CDMOs
• 1.2 Supply Chain /Value Overview
  • 1.2.1 Supply Chain and Risks within the Supply Chain
  • 1.2.2 Value Chain Analysis
• 1.3 Pricing Analysis
• 1.4 Patent Filing Trend (by Year, Country)
• 1.5 Regulatory Landscape
• 1.6 Impact Analysis for Key Global Events - COVID-19
• 1.7 Market Dynamics: Overview
  • 1.7.1 Market Drivers
    • 1.7.1.1 Increasing Incidence of Cancer Leading to Demand in the Adoption of Highly Potent APIs
    • 1.7.1.2 Advancements in Drug Delivery Technologies
    • 1.7.1.3 Expanding Therapeutic Applications of Highly Potent API
  • 1.7.2 Market Opportunities
    • 1.7.2.1 Growing Emphasis on Personalized Medicine
    • 1.7.2.2 Increasing Opportunities for Pharma Companies in Developing Markets
  • 1.7.3 Market Restraints
    • 1.7.3.1 Regulatory Complexity for Highly Potent APIs' Manufacturing
    • 1.7.3.2 High Development and Production Costs

2 Regions

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 China
  • 2.2.5 India
  • 2.2.6 Japan
  • 2.2.7 Australia
  • 2.2.8 South Korea
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets -Competitive Benchmarking & Company Profiles

• 3.1 Next Frontiers
• 3.2 Geographic Assessment
  • 3.2.1 Asymchem Inc.
    • 3.2.1.1 Overview
    • 3.2.1.2 Key Developments
    • 3.2.1.3 Top Products/Product/Service Portfolio
    • 3.2.1.4 Top Competitors
    • 3.2.1.5 Key Personnel
    • 3.2.1.6 Analyst View
  • 3.2.2 Dr. Reddy's Laboratories Ltd.
    • 3.2.2.1 Overview
    • 3.2.2.2 Key Developments
    • 3.2.2.3 Top Products/Product/Service Portfolio
    • 3.2.2.4 Top Competitors
    • 3.2.2.5 Key Personnel
    • 3.2.2.6 Analyst View
  • 3.2.3 CARBOGEN AMCIS
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products/Product/Service Portfolio
    • 3.2.3.3 Key Developments
    • 3.2.3.4 Top Competitors
    • 3.2.3.5 Key Personnel
    • 3.2.3.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast